Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Ripped From the Headlines of ACC: DanGer Shock RCT Results

A panel of interventional cardiologists discuss the DanGer Shock RCT results and the implications for AMICS patient management.

European Best Practice A Step Forward to Optimize Impella-Protected Percutaneous Coronary Intervention To Improve Outcomes After High-Risk Coronary Interventions

This overview article provides a framework for this series of articles. It addresses European recommendations and best practices for patient management and mechanical circulatory support (MCS) during high risk intervention, highlighting the following topics...

Babar Basir: Best Practices in Revascularization in Cardiogenic Shock

Babar Basir, D.O., discusses revascularization best practices in patients with cardiogenic shock.

Optimal Bail-Out and Complication Management Strategies in Protected High-Risk Percutaneous Coronary Intervention With the Impella Heart Pump

In this article the authors describe techniques for Impella heart pump removal with or without pre-closure and discuss how to prevent and manage complications associated with large-bore femoral access.

Handling High-Risk Patients in the Catheterization Laboratory

This article describes how the interventional cardiology team handles high-risk patients in the cath lab, from procedural preparation and planning through procedural monitoring, as well as weaning strategies and access site management.

EuroPCR 2023 How to Optimize High-Risk PCI Patient Outcome: Opening and Session Objectives

Javier Escaned, MD, opens the session titled “How to optimize high-risk patient outcome?” at EuroPCR 2023.

EuroPCR 2023: Complete Revascularization with pVAD vs IABP

Vasileios Panoulas, MD, discusses data regarding completeness of revascularization in high-risk PCI with mechanical circulatory support (MCS) at EuroPCR 2023.

EuroPCR 2023: How To Optimize High-Risk PCI Patient Outcome: Discussion and Audience Interaction

Javier Escaned, MD, Nikos Werner, MD, Dirk Westermann, MD, and Vasileios Panoulas, MD, answer questions following the EuroPCR session “How to optimize high-risk patient outcome?”

What Is Known in Pre-, Peri- and Post-Procedural Anticoagulation in Micro-Axial Flow Pump Protected Percutaneous Coronary Intervention?

“The precarious balance between bleeding and thrombosis in patients with p-LVAD support is often the primary reason that patients’ outcomes are jeopardized,” write the authors of this article, which discusses anticoagulation strategies and anticoagulant management in the setting of Protected PCI.

Standardized Pre-Procedural Clinical Workup for Protected Percutaneous Coronary Intervention

This article describes pre-procedural preparation, with a particular focus on imaging techniques for screening and guiding vascular access in patients undergoing Protected PCI.

Tampa General Heart Team: High-Risk Revascularization

Four physicians from the heart team at Tampa General Hospital discuss their approach to high-risk revascularization in patients with heart failure.

Pre-Procedural Clinical Workup for Protected PCI

Fadi Al-Rashid, MD, discusses his publication on standard pre-procedural clinical workup for Protected PCI.

Optimal Revascularization Strategies During Protected PCI

Prof. Dr. Jan-Malte Sinning discusses optimal revascularization strategies during protected high-risk procedures with Impella® heart pumps.

cVAD Registry v. Insurance Databases

William O’Neill, MD, and Alejandro Lemor, MD, compare insurance databases to the cVAD registry and discuss factors that characterize high-risk patients requiring MCS.

Alejandro Lemor, MD: A-SMART-EF Score

Alejandro F. Lemor, MD, disusses A-SMART-EF, a new risk score for predicting outcomes in patients supported with Impella® during PCI.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].